Personalized CRISPR therapies could soon reach thousands — here’s how
Publication details
Published 2026
Blood,
Brain,
Eye,
Genomics,
Delivery
University of California, Berkeley - IGI
10.1038/d41586-026-01243-y
Nature . 2026 Apr;652(8111):857-859. doi: 10.1038/d41586-026-01243-y
A fresh approach to trialling treatments for rare genetic diseases could make their production an economically viable prospect at last.
Keywords: CRISPR-Cas9 genome editing; Genetics; Medical research; Personalized medicine; Policy.
Related publications
